Taiwan Advance Bio-Pharmaceutical Inc.

4186

TW0004186002

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-06-27 EDT			5-day change	1st Jan Change
19.55 ^TWD	+2.89%		+3.44%	+18.48%

04-19	Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Taiwan Advance Bio-Pharmaceutical Inc. announced a financing transaction.

March 16, 2014

Taiwan Advance Bio-Pharmaceutical Inc. (GTSM:4186) announced a private placement of 5,000,000 common shares on March 17, 2014. The company will issue shares in one year.

Latest news about Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-24	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-11	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-25	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-12	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-26	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-13	CI
Taiwan Advance Bio-Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-28	CI
Taiwan Advance Bio-Pharmaceutical Inc. cancelled the transaction announced on March 17, 2014	15-03-31	CI
Taiwan Advance Bio-Pharmaceutical Inc. announced a financing transaction.	14-03-16	CI

Chart Taiwan Advance Bio-Pharmaceutical Inc.

Duration

Period

Chart Taiwan Advance Bio-Pharmaceutical Inc.

More charts

Taiwan Advance Bio-Pharmaceutical Inc. is a Taiwan-based company principally engaged in the research, development, production and sales of drug residue test reagents. The Company is also involved in drug abuse testing business, the development and storage of cord blood stem cells, as well as the provision of biotechnology services. The Company operates its businesses in domestic market and overseas markets, such as the rest areas of Asia and Europe.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.	+18.48%	54.16M
LONZA GROUP AG	+38.65%	39.36B
IQVIA HOLDINGS INC.	-8.62%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+26.95%	30.74B
ICON PUBLIC LIMITED COMPANY	+10.74%	25.92B
CELLTRION, INC.	-13.50%	26.03B
UNITED THERAPEUTICS CORPORATION	+44.87%	14.13B
MEDPACE HOLDINGS, INC.	+34.36%	12.73B
BIO-TECHNE CORPORATION	-7.14%	11.29B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-12.61%	10.64B